Stay updated on EGFR Mutant Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.

Latest updates to the EGFR Mutant Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check46 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on Nivolumab and Ipilimumab in treating advanced EGFR+ NSCLC, while adding new collaborators and a revision number.SummaryDifference55%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to EGFR Mutant Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EGFR Mutant Lung Cancer Clinical Trial page.